HPC — Hydration Pharmaceuticals Co Balance Sheet
0.000.00%
Last trade - 00:00- AU$1.72m
- AU$0.14m
- $2.47m
Annual balance sheet for Hydration Pharmaceuticals Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 10.7 | 4.69 | 1.84 | 3.22 | 1.12 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.01 | 1.31 | 1.75 | 0.353 | 0.08 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 15.3 | 10.4 | 6.69 | 5 | 2.19 |
| Net Property, Plant And Equipment | 0 | — | — | — | — |
| Other Long Term Assets | |||||
| Total Assets | 15.3 | 10.4 | 6.69 | 5 | 2.19 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.06 | 2.68 | 3.13 | 2.23 | 0.774 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.08 | 6.41 | 7.05 | 2.25 | 0.774 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 13.2 | 3.98 | -0.358 | 2.74 | 1.42 |
| Total Liabilities & Shareholders' Equity | 15.3 | 10.4 | 6.69 | 5 | 2.19 |
| Total Common Shares Outstanding |